This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
whole | blood | 655 |
chronic | hepatitis | 626 |
red | blood | 556 |
red | cell | 471 |
- | time | 388 |
red | cells | 307 |
- | cell | 261 |
- | transfusion | 235 |
chronic | hbv | 185 |
chronic | liver | 153 |
viral | infections | 149 |
viral | infection | 127 |
first | time | 123 |
immune | system | 113 |
severe | hepatitis | 112 |
positive | samples | 110 |
viral | hepatitis | 109 |
positive | results | 106 |
- | infection | 103 |
high | risk | 99 |
- | risk | 97 |
positive | patients | 92 |
viral | proteins | 90 |
antiviral | treatment | 88 |
specific | antibodies | 86 |
acute | liver | 80 |
high | level | 77 |
viral | protein | 71 |
acute | hepatitis | 65 |
- | blood | 64 |
- | treatment | 64 |
human | hepatitis | 63 |
chronic | infection | 62 |
- | b | 57 |
- | antibodies | 56 |
negative | blood | 55 |
negative | patients | 53 |
higher | risk | 51 |
positive | donors | 50 |
positive | result | 48 |
significant | antibodies | 46 |
other | viruses | 46 |
positive | antibody | 45 |
high | levels | 43 |
low | level | 42 |
other | studies | 42 |
- | platelet | 41 |
clinical | samples | 41 |
other | blood | 40 |
severe | cases | 40 |
severe | liver | 40 |
severe | disease | 39 |
low | levels | 39 |
positive | cells | 39 |
effective | treatment | 36 |
- | hepatitis | 35 |
positive | blood | 35 |
- | antibody | 34 |
- | hbv | 34 |
clinical | studies | 34 |
new | donors | 34 |
negative | results | 33 |
low | risk | 33 |
different | blood | 33 |
- | donors | 32 |
- | cells | 32 |
acute | hbv | 29 |
acute | infection | 29 |
- | antigen | 28 |
- | level | 27 |
high | hbv | 26 |
new | blood | 26 |
- | patients | 26 |
- | day | 26 |
negative | result | 25 |
- | donor | 24 |
- | protein | 24 |
- | virus | 24 |
human | platelet | 24 |
specific | antibody | 23 |
viral | antigen | 23 |
viral | antigens | 23 |
human | liver | 22 |
different | methods | 22 |
chronic | disease | 21 |
other | groups | 21 |
viral | diseases | 21 |
human | cells | 21 |
immune | cells | 21 |
first | transfusion | 20 |
clinical | study | 19 |
different | time | 19 |
negative | donors | 19 |
negative | samples | 19 |
higher | levels | 18 |
other | diseases | 18 |
such | patients | 18 |
- | unit | 17 |
human | infection | 17 |
- | system | 16 |
low | blood | 16 |
other | patients | 16 |
severe | transfusion | 16 |
first | blood | 15 |
other | methods | 15 |
human | blood | 15 |
- | liver | 15 |
- | group | 15 |
- | patient | 14 |
- | sample | 14 |
clinical | transfusion | 14 |
first | study | 14 |
other | infections | 14 |
specific | antigens | 14 |
positive | group | 13 |
such | cases | 13 |
specific | blood | 13 |
significant | risk | 13 |
first | case | 13 |
positive | donor | 13 |
large | sample | 13 |
high | blood | 13 |
different | viruses | 13 |
lower | risk | 12 |
large | blood | 12 |
immune | cell | 12 |
immune | antibodies | 12 |
lower | levels | 11 |
specific | virus | 11 |
severe | infection | 11 |
other | day | 11 |
more | units | 11 |
new | method | 11 |
low | platelet | 11 |
human | diseases | 11 |
highest | level | 11 |
different | levels | 11 |
different | groups | 11 |
higher | platelet | 10 |
specific | treatment | 10 |
other | antigens | 10 |
negative | group | 10 |
negative | antibody | 10 |
human | disease | 10 |
different | hbv | 10 |
common | antibody | 10 |
clinical | disease | 10 |
clinical | cases | 10 |
available | blood | 10 |
- | units | 10 |
significant | antigens | 9 |
positive | cases | 9 |
other | proteins | 9 |
other | patient | 9 |
other | antibodies | 9 |
new | virus | 9 |
human | hbv | 9 |
first | patient | 9 |
effective | blood | 9 |
high | platelet | 8 |
positive | sample | 8 |
other | donors | 8 |
other | cases | 8 |
low | hbv | 8 |
larger | study | 8 |
effective | method | 8 |
first | results | 8 |
different | patient | 8 |
- | platelets | 8 |
- | groups | 8 |
- | case | 8 |
important | viruses | 7 |
such | studies | 7 |
positive | platelets | 7 |
other | virus | 7 |
other | risks | 7 |
other | cells | 7 |
negative | hbv | 7 |
large | group | 7 |
new | donor | 7 |
important | blood | 7 |
human | infections | 7 |
human | cell | 7 |
human | cases | 7 |
first | group | 7 |
first | day | 7 |
different | studies | 7 |
clinical | treatment | 7 |
human | platelets | 7 |
new | b | 6 |
more | studies | 6 |
more | time | 6 |
negative | hepatitis | 6 |
new | antibodies | 6 |
specific | risks | 6 |
new | cases | 6 |
new | platelet | 6 |
specific | group | 6 |
specific | hbv | 6 |
important | risk | 6 |
more | patients | 6 |
high | cell | 6 |
human | viruses | 6 |
different | cell | 6 |
highest | risk | 6 |
- | antigens | 6 |
- | times | 6 |
common | disease | 6 |
chronic | blood | 6 |
different | diseases | 6 |
effective | methods | 6 |
high | antibody | 6 |
higher | level | 6 |
significant | blood | 5 |
new | infections | 5 |
new | risk | 5 |
new | system | 5 |
new | viruses | 5 |
positive | hbv | 5 |
severe | infections | 5 |
whole | system | 5 |
specific | antigen | 5 |
specific | groups | 5 |
such | transfusions | 5 |
whole | cell | 5 |
whole | transfusion | 5 |
lower | level | 5 |
more | donors | 5 |
antiviral | treatments | 5 |
human | studies | 5 |
chronic | transfusion | 5 |
different | donors | 5 |
- | disease | 5 |
- | levels | 5 |
- | studied | 5 |
antiviral | protein | 5 |
chronic | patients | 5 |
- | infections | 5 |
clinical | case | 5 |
different | cells | 5 |
clinical | hepatitis | 5 |
clinical | patients | 5 |
common | donor | 5 |
common | infections | 5 |
significant | antibody | 4 |
positive | units | 4 |
positive | patient | 4 |
other | transfusion | 4 |
other | systems | 4 |
other | platelet | 4 |
other | samples | 4 |
other | risk | 4 |
new | methods | 4 |
other | hepatitis | 4 |
new | treatment | 4 |
significant | infection | 4 |
significant | disease | 4 |
such | diseases | 4 |
significant | liver | 4 |
significant | platelet | 4 |
significant | transfusion | 4 |
specific | results | 4 |
specific | risk | 4 |
specific | viruses | 4 |
such | donors | 4 |
such | infections | 4 |
such | treatment | 4 |
viral | disease | 4 |
viral | risk | 4 |
new | hepatitis | 4 |
new | level | 4 |
acute | blood | 4 |
new | antibody | 4 |
higher | donor | 4 |
- | result | 4 |
negative | donor | 4 |
- | systems | 4 |
chronic | infections | 4 |
chronic | transfusions | 4 |
common | infection | 4 |
different | platelet | 4 |
different | sample | 4 |
different | treatment | 4 |
first | result | 4 |
high | sample | 4 |
different | antigens | 4 |
higher | hbv | 4 |
large | studies | 4 |
more | transfusions | 4 |
human | patients | 4 |
more | days | 4 |
more | antigens | 4 |
larger | sample | 4 |
more | infections | 4 |
human | protein | 4 |
human | virus | 4 |
human | study | 4 |
large | platelets | 4 |
negative | studied | 3 |
other | sample | 3 |
other | hbv | 3 |
other | case | 3 |
new | hbv | 3 |
new | cell | 3 |
other | units | 3 |
more | viruses | 3 |
more | groups | 3 |
more | donor | 3 |
more | blood | 3 |
lowest | level | 3 |
lower | blood | 3 |
other | treatments | 3 |
whole | donor | 3 |
others | donors | 3 |
positive | transfusions | 3 |
severe | blood | 3 |
specific | cell | 3 |
specific | disease | 3 |
specific | infection | 3 |
specific | proteins | 3 |
such | antibodies | 3 |
such | cells | 3 |
viral | risks | 3 |
viral | treatment | 3 |
whole | virus | 3 |
low | antibody | 3 |
low | hepatitis | 3 |
available | treatments | 3 |
larger | studies | 3 |
different | group | 3 |
larger | samples | 3 |
- | treatments | 3 |
acute | infections | 3 |
anti | b | 3 |
anti | hbv | 3 |
available | hbv | 3 |
chronic | platelet | 3 |
clinical | blood | 3 |
clinical | results | 3 |
common | antibodies | 3 |
common | viruses | 3 |
commonest | antibodies | 3 |
different | days | 3 |
chronic | diseases | 3 |
different | liver | 3 |
human | antibody | 3 |
different | times | 3 |
larger | patient | 3 |
larger | groups | 3 |
large | study | 3 |
immune | platelet | 3 |
large | donor | 3 |
high | transfusion | 3 |
high | protein | 3 |
high | donor | 3 |
first | unit | 3 |
effective | treatments | 3 |
other | cell | 2 |
negative | patient | 2 |
non | hbv | 2 |
new | studies | 2 |
new | patients | 2 |
new | group | 2 |
negative | units | 2 |
negative | sample | 2 |
more | times | 2 |
negative | groups | 2 |
negative | cells | 2 |
negative | cases | 2 |
negative | antigens | 2 |
more | virus | 2 |
more | samples | 2 |
other | liver | 2 |
other | donor | 2 |
such | units | 2 |
other | method | 2 |
other | treatment | 2 |
whole | disease | 2 |
viral | liver | 2 |
more | hbv | 2 |
such | blood | 2 |
specific | transfusion | 2 |
specific | patients | 2 |
specific | patient | 2 |
significant | results | 2 |
severe | patients | 2 |
severe | diseases | 2 |
positive | transfusion | 2 |
positive | platelet | 2 |
positive | liver | 2 |
positive | hepatitis | 2 |
positive | groups | 2 |
more | platelet | 2 |
specific | diseases | 2 |
more | cases | 2 |
clinical | infection | 2 |
common | virus | 2 |
common | liver | 2 |
common | blood | 2 |
common | antigens | 2 |
common | antigen | 2 |
clinical | sample | 2 |
clinical | platelet | 2 |
chronic | cases | 2 |
different | donor | 2 |
available | treatment | 2 |
available | systems | 2 |
available | methods | 2 |
acute | cases | 2 |
- | proteins | 2 |
- | days | 2 |
lower | transfusion | 2 |
different | disease | 2 |
clinical | liver | 2 |
different | patients | 2 |
immune | diseases | 2 |
lower | day | 2 |
lower | hbv | 2 |
different | results | 2 |
lower | cell | 2 |
large | protein | 2 |
large | cell | 2 |
important | protein | 2 |
important | antigens | 2 |
important | treatment | 2 |
human | risk | 2 |
higher | risks | 2 |
high | treatment | 2 |
high | infection | 2 |
effective | transfusion | 2 |
different | virus | 2 |
lowest | risk | 1 |
lower | protein | 1 |
negative | antigen | 1 |
more | antibodies | 1 |
more | protein | 1 |
more | proteins | 1 |
more | results | 1 |
more | risk | 1 |
more | transfusion | 1 |
new | antigens | 1 |
negative | case | 1 |
negative | cell | 1 |
negative | platelet | 1 |
negative | platelets | 1 |
negative | treatment | 1 |
negative | unit | 1 |
new | case | 1 |
new | infection | 1 |
lower | hepatitis | 1 |
lower | platelet | 1 |
large | samples | 1 |
lower | disease | 1 |
lower | antibody | 1 |
large | hbv | 1 |
large | hepatitis | 1 |
large | liver | 1 |
large | proteins | 1 |
new | platelets | 1 |
large | virus | 1 |
larger | donor | 1 |
larger | platelets | 1 |
larger | results | 1 |
larger | viruses | 1 |
largest | blood | 1 |
largest | case | 1 |
largest | group | 1 |
largest | study | 1 |
low | antigen | 1 |
low | cell | 1 |
low | patients | 1 |
low | results | 1 |
low | virus | 1 |
new | patient | 1 |
severe | risk | 1 |
new | risks | 1 |
such | virus | 1 |
specific | studies | 1 |
specific | treatments | 1 |
such | hbv | 1 |
such | infection | 1 |
such | proteins | 1 |
such | results | 1 |
such | time | 1 |
such | transfusion | 1 |
viral | cell | 1 |
specific | platelet | 1 |
viral | group | 1 |
viral | systems | 1 |
viral | transfusion | 1 |
viral | viruses | 1 |
whole | group | 1 |
whole | hbv | 1 |
whole | liver | 1 |
important | studies | 1 |
specific | protein | 1 |
specific | methods | 1 |
new | sample | 1 |
other | system | 1 |
new | study | 1 |
new | systems | 1 |
new | transfusion | 1 |
new | unit | 1 |
other | antigen | 1 |
other | disease | 1 |
other | studied | 1 |
other | study | 1 |
other | unit | 1 |
specific | infections | 1 |
positive | case | 1 |
positive | cell | 1 |
positive | livers | 1 |
severe | group | 1 |
significant | levels | 1 |
specific | case | 1 |
specific | cells | 1 |
specific | day | 1 |
important | transfusion | 1 |
different | antigen | 1 |
important | proteins | 1 |
common | hbv | 1 |
chronic | virus | 1 |
clinical | groups | 1 |
clinical | levels | 1 |
clinical | risk | 1 |
clinical | treatments | 1 |
clinical | unit | 1 |
clinical | units | 1 |
common | group | 1 |
common | platelet | 1 |
chronic | antigen | 1 |
common | protein | 1 |
common | risk | 1 |
common | treatment | 1 |
different | antibody | 1 |
different | hepatitis | 1 |
different | level | 1 |
different | proteins | 1 |
different | risk | 1 |
chronic | treatment | 1 |
available | studies | 1 |
different | transfusion | 1 |
acute | treatment | 1 |
- | diseases | 1 |
- | risks | 1 |
- | sampled | 1 |
- | samples | 1 |
- | timed | 1 |
- | viruses | 1 |
acute | disease | 1 |
acute | patients | 1 |
acute | virus | 1 |
available | platelet | 1 |
antiviral | antibody | 1 |
antiviral | cell | 1 |
antiviral | infection | 1 |
antiviral | infections | 1 |
antiviral | studies | 1 |
antiviral | system | 1 |
available | hepatitis | 1 |
available | method | 1 |
different | systems | 1 |
different | treatments | 1 |
important | day | 1 |
highest | time | 1 |
higher | infection | 1 |
higher | patient | 1 |
higher | sample | 1 |
highest | blood | 1 |
highest | hbv | 1 |
highest | levels | 1 |
highest | liver | 1 |
highest | platelet | 1 |
human | case | 1 |
higher | % | 1 |
human | donor | 1 |
human | group | 1 |
human | samples | 1 |
immune | liver | 1 |
immune | protein | 1 |
immune | systems | 1 |
important | antigen | 1 |
important | cells | 1 |
higher | cell | 1 |
high | virus | 1 |
effective | antibodies | 1 |
first | cell | 1 |
effective | donors | 1 |
effective | infection | 1 |
effective | level | 1 |
effective | proteins | 1 |
effective | risk | 1 |
effective | system | 1 |
effective | time | 1 |
first | antibody | 1 |
first | cells | 1 |
high | liver | 1 |
first | days | 1 |
first | disease | 1 |
first | donor | 1 |
first | level | 1 |
first | patients | 1 |
first | resulted | 1 |
first | sample | 1 |
first | studies | 1 |
whole | study | 1 |